Tag Archives | RMU

Medicine Use Evaluations: A strategy for therapeutics committees to monitor the use of antiretroviral medicines and medicines for opportunistic infections

This manual is intended to assist therapeutic committees (TCs) in monitoring medicine use in their health facilities through regular medicine use evaluations (MUEs). The manual lists and describes the various steps involved in conducting an MUE. It also:

  • describes the conditions of rational use of medicines (RUM)
  • describes the extent and nature of the inappropriate use of medicines
  • seeks to raise awareness of practices that lead to the development of antimicrobial resistance (AMR)
  • describes and discusses irrationalities pertaining to the use of antimicrobials, including those used in the treatment of HIV and AIDS and TB
  • helps TCs to understand the adverse impacts of inappropriate medicine use
  • highlights roles of TCs in promoting RUM
  • supports TCs in designing action plans to improve medicine use in their health facilities
  • supports TCs in drafting interventions to improve poor performance as it relates to the pharmaceutical management information system (PMIS), supportive supervision visits (SSVs), and antiretroviral therapy (ART) early warning indicators (EWIs) of HIV drug resistance (HIV-DR).
Read full story · Comments are closed

August 2015 SIAPS/SCMS/BLC Newsletter

In this issue:

  • Launch of Infection Prevention and Control Manuals, Creating Awareness on Antimicrobial Resistance and Rational Medicine Use
  • Building the Supply Chain Capacity to Extend Health Services to the Community
  • High Employer Satisfaction with Pharmacist Assistants Trained by the NHTC: A Tracer Study Reveals
  • Improving Availability of ARVs at Primary Health Care Facilities in HIV/AIDS-Burdened Regions in Namibia
  • Improving the Supply Chain Efficiency of Medical Depots for the Continuous Availability of ARVs and Other Essential Medicines in Namibia
  • SIAPS Collaborates with Namibia’s Medical School in Building Local Expertise for Preventing Antimicrobial Resistance and Hospital Acquired Infections
  • Sharing Experiences and Lessons to Improve Pharmaceutical Service Delivery
Read full story · Comments are closed

Mitigating antimicrobial resistance: Preventing resistance to HIV medications in Namibia

The USAID-funded SIAPS program has been influential in designing Namibia’s approach to preventing the development of antimicrobial resistance including HIV drug resistance. Due to the rapid scale-up of ART services, Namibia has achieved high ART coverage of the HIV-positive population. Although it can be minimized, HIV drug resistance (HIV-DR) is anticipated to emerge among people […]

Read full story · Comments { 0 }

Sentinel Site Active Surveillance of the Safety of First-Line Antiretroviral Medicines in Windhoek Central Hospital and Katutura Intermediate Hospital

In the Republic of Namibia, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program receives funding from the US Government to provide technical guidance for the development and implementation of innovative strategies and programs to strengthen pharmaceutical systems in support of the HIV/AIDS program. SIAPS is collaborating with USAID/Namibia to ensure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes for the government of the Republic of Namibia.

The Therapeutics Information and Pharmacovigilance Centre (TIPC) is responsible for the promotion of the rational and safe use of medicines in Namibia. Officially launched in 2008 as part of the Ministry of Health and Social Services (MoHSS), it is the official centre for the provision of unbiased therapeutics information and pharmacovigilance services to health care professionals and the general public. The Centre became the 90th full member of the World Health Organization (WHO) Programme for International Drug Monitoring in 2008.

The SIAPS Program in Namibia supports the implementation of initiatives to improve treatment outcomes through strategies that promote pharmacovigilance at the health facility and community levels. Additionally, in collaboration with UW, SIAPS is providing technical guidance towards the implementation of medication risk management strategies at selected referral hospitals in Namibia. In FY12, SIAPS supported the initiation of prospective active surveillance of the safety of antiretroviral medicines at the Windhoek Central Hospital and the Katutura Intermediate Hospital. In FY13, SIAPS continued to provide technical assistance towards the implementation of prospective active surveillance of ARV medicines so that the collected data is managed accurately, and to ensure that the active surveillance system is a long-term and beneficial investment.

Read full story · Comments are closed

Containing Antimicrobial Resistance Through Integrated Community Case Management

The integrated community case management (iCCM) of common killers of children under five (diarrhea, pneumonia and malaria) has been implemented in many low-income countries to increase access to treatment and prevent child deaths. iCCM, which has been hailed as a successful strategy by the WHO and UNICEF, involves the delivery of timely and low-cost interventions […]

Read full story · Comments { 0 }

Using a Health-Systems-Strengthening Approach to Contain AMR: A South African Experience

“Antimicrobial resistance (AMR) is a major threat to the long-term security of public health and has the potential to negatively impact our society. It is a serious and growing global health security risk, which needs to be prioritised at local and international levels.”- Dr. Aaron Motsoaledi, South African Minister of Health In May 2014, the […]

Read full story · Comments { 1 }

Fighting Antimicrobial Resistance with Pre-Service Training

The irrational use of medicines, a major driver of antimicrobial resistance (AMR), is often perpetuated by those who should be best able to stop it—health care professionals such as doctors and pharmacists. This, of course, raises an important question: why do health care professionals continue to practice potentially harmful behaviors? In many cases, the answer […]

Read full story · Comments { 2 }

Taking a Stand against Antimicrobial Resistance: Strengthening Systems to Promote the Rational Use of Medicines

A year ago, the World Health Organization (WHO) released its first global report on antimicrobial resistance, revealing a number of troubling trends: rising rates of resistance to first-line antibiotics for common infections such as urinary tract infections, gonorrhoea, and staph infections; a growing inability to treat deadly diseases like tuberculosis (TB) with second-line and even […]

Read full story · Comments { 1 }